戻る Agenda
Session 3 : Utilization of the J-PACMP system for Cell and Gene Therapy Products (Japanese)
Session Chair(s)
![Teruyo Arato, PhD](/_Images/member/Generic_Image_Missing-Profile.jpg)
Teruyo Arato, PhD
Professor, Clinical Research and Medical Innovation Center
Hokkaido University Hospital, Japan
![Ryutaro Hirasawa](/_Images/member/Generic_Image_Missing-Profile.jpg)
Ryutaro Hirasawa
CMC Regulatory Affairs, Manager
Daiichi Sankyo Co., Ltd., Japan
Speaker(s)
![Jun Matsumoto](/_Images/member/Generic_Image_Missing-Profile.jpg)
Jun Matsumoto
Pharmaceuticals and Medical Devices Agency (PMDA), Japan
Reviewer, Office of Biologics I
![Yuriko Ishii](/_Images/member/Generic_Image_Missing-Profile.jpg)
Yuriko Ishii
Daiichi Sankyo Co., Ltd, Japan
Associate Director, CMC Reguratory Affairs Department
Keigo Kawabe
Sumitomo Pharma Co.,Ltd., Japan
Quality Officer, Regenerative & Cellular Medicine Office
Naoyuki Hanada
Novartis Pharma K.K., Japan
Regulatory CMC